Evidence map›Paper›PMID 34620665›Full record

ArticleBMJ open2021

Cohort profile: Indian Network of Population-Based Surveillance Platforms for Influenza and Other Respiratory Viruses among the Elderly (INSPIRE).

Anand Krishnan, Lalit Dar, Ritvik Amarchand, Aslesh Ottapura Prabhakaran, Rakesh Kumar, Prabu Rajkumar, Suman Kanungo, Sumit Dutt Bhardwaj, Avinash Choudekar, Varsha Potdar and 9 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Monitoring influenza vaccination coverage among older adults: a rural cohort study, Rio Grande, 2017-2022.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Influenza vaccine: a review on current scenario and future prospects.Journal, genetic engineering & biotechnology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Anand KrishnanCentre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India anand.drk@gmail.com.
Lalit DarDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Ritvik AmarchandCentre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
Aslesh Ottapura PrabhakaranInfluenza program, US Centers for Disease Control and Prevention, New Delhi, India.
Rakesh KumarCentre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
Prabu RajkumarNational Institute of Epidemiology, Chennai, India.ORCID 0000-0001-9839-800X
Suman KanungoNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Sumit Dutt BhardwajNational Institute of Virology, Pune, India.
Avinash ChoudekarDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Varsha PotdarNational Institute of Virology, Pune, India.
Alok Kumar ChakrabartiNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Cp Girish KumarNational Institute of Epidemiology, Chennai, India.
Giridara Gopal ParameswaranCentre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0002-2238-6843
Shivram DhakadDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Byomkesh MannaNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Ashish ChoudharyDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Kathryn E LafondInfluenza division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Eduardo Azziz-BaumgartnerInfluenza division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Siddhartha SahaInfluenza program, US Centers for Disease Control and Prevention, New Delhi, India.
All India Institute of Medical Sciences · INNational Institute of Cholera and Enteric Diseases · INCenters for Disease Control and Prevention · USICMR-National Institute of Virology · INNational Center for Disease Control · INNational Institute of Epidemiology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe describe here a multicentric community-dwelling cohort of older adults (

participantsThe four sites of this cohort are in northern (Ballabgarh), southern (Chennai), eastern (Kolkata) and western (Pune) parts of India. We enrolled 5336 participants across 4220 households and began surveillance in July 2018 for viral respiratory infections with additional participants enrolled annually. Trained field workers collected data about individual-level and household-level risk factors at enrolment and quarterly assessed frailty and grip strength. Trained nurses surveilled weekly to identify acute respiratory infections (ARI) and clinically assessed individuals to diagnose acute lower respiratory infection (ALRI) as per protocol. Nasal and oropharyngeal swabs are collected from all ALRI cases and one-fifth of the other ARI cases for laboratory testing. Cost data of the episode are collected using the WHO approach for estimating the economic burden of seasonal influenza. Handheld tablets with Open Data Kit platform were used for data collection. FINDINGS TO DATE: The attrition of 352 participants due to migration and deaths was offset by enrolling 680 new entrants in the second year. All four sites reported negligible influenza vaccination uptake (0.1%-0.4%), low health insurance coverage (0.4%-22%) and high tobacco use (19%-52%). Ballabgarh had the highest proportion (54.4%) of households in the richest wealth quintile, but reported high solid fuel use (92%). Frailty levels were highest in Kolkata (11.3%) and lowest in Pune (6.8%). The Chennai cohort had highest self-reported morbidity (90.1%). FUTURE PLANS: The findings of this cohort will be used to inform prioritisation of strategies for influenza and RSV control for older adults in India. We also plan to conduct epidemiological studies of SARS-CoV-2 using this platform.

Indexed as

COVID-19Influenza, HumanRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsVirusesAgedHumansIndiaInfantSARS-CoV-2epidemiologyinfectious diseasespublic health

Identifiers

PMID34620665
PMCPMC8499317
OpenAlexW3203528784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.